Navigation Links
Sabre 180, 100V, 50Hz/60Hz

ProductsSabre 180, 100V, 50Hz/60Hz
Company CONMED Corporation
Item Sabre 180, 100V, 50Hz/60Hz
Features ARM Contact Quality (sensitive pad monitoring system)
Description Sabre 180 is a powerful niche generator.
Info CONMED Corporation
Customer Service: (315) 797-8375
Web site: http://www.conmed.com/

Related medicine products :

1. Sabre 2400
2. Sabre 180
3. Sabre 2400, 110V, 60Hz
4. Sabre 2400, 100V, 50Hz/60Hz
5. Sabre 2400, 220V, 50Hz
6. Sabre 2400, 240V, 50Hz
7. Sabre 180, 110V, 60Hz
8. Sabre 180, 230V, 50Hz
9. Sabre 2400 Electrosurgery Generator, 110V, 60Hz
10. Sabre 2400 Electrosurgery Generator, 100V, 50Hz/60Hz
11. Sabre 2400 Electrosurgery Generator, 220V, 50Hz
TAG: Sabre
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Circadiance Launches NEW Zzzephyr Seal 28TM 29 for Its SleepWeaver 28TM 29 ADVANCE Mask Now Available in Three Colors 60056 1Circadiance Launches NEW Zzzephyr Seal 28TM 29 for Its SleepWeaver 28TM 29 ADVANCE Mask Now Available in Three Colors 60056 2STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 1STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 2STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 3STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 4STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 5STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 6Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 1Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 2Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 3